Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
QuintilesIMS
Harvard Business School
Daiichi Sankyo
Merck
Moodys

Generated: June 16, 2019

DrugPatentWatch Database Preview

Amneal Pharms Co Company Profile

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARMS CO, and what generic and branded alternatives to AMNEAL PHARMS CO drugs are available?

AMNEAL PHARMS CO has sixty-one approved drugs.

There are two tentative approvals on AMNEAL PHARMS CO drugs.

Summary for Amneal Pharms Co
US Patents:0
Tradenames:58
Ingredients:57
NDAs:61

Drugs and US Patents for Amneal Pharms Co

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co NEOSTIGMINE METHYLSULFATE neostigmine methylsulfate SOLUTION;INTRAVENOUS 210051-002 Jun 15, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms Co TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 208840-001 Feb 28, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Amneal Pharms Co TERIFLUNOMIDE teriflunomide TABLET;ORAL 209613-002 Sep 28, 2018 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for AMNEAL PHARMS CO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Johnson and Johnson
Boehringer Ingelheim
McKesson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.